Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Autologous Cell Therapy Market (2022-2027): Emphasis on Drug Development for New Applications Drives Growth -

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 22, 2022 GMT

DUBLIN--(BUSINESS WIRE)--Dec 22, 2022--

The “Global Autologous Cell Therapy Market (2022-2027) by Source, Applications, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to’s offering.

The Global Autologous Cell Therapy Market is estimated to be USD 8.9 Bn in 2022 and is expected to reach USD 18.14 Bn by 2027, growing at a CAGR of 15.3%.

Market Dynamics


  • Rising Incidence of Chronic Diseases
  • Emphasis on Drug Development for New Applications


  • Systemic Immunological Reactions Possibility
  • High Capital Investment


  • Extensive Research and Development


  • Risks and Complications Associated with the Therapy

Market Segmentations

The Global Autologous Cell Therapy Market is segmented based on Source, Applications, End-Users, and Geography.

  • By Source, the market is classified into Bone Marrow and Epidermis.
  • By Applications, the market is classified into Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD, and Autoimmune Diseases.
  • By End-Users, the market is classified into Hospitals, Ambulatory Centers, and Research Centers.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Autologous Cell Therapy Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Autologous Cell Therapy Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Autologous Cell Therapy Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Autologous Cell Therapy Market, By Source

7 Global Autologous Cell Therapy Market, By Applications

8 Global Autologous Cell Therapy Market, By End-Users

9 Americas’ Autologous Cell Therapy Market

10 Europe’s Autologous Cell Therapy Market

11 Middle East and Africa’s Autologous Cell Therapy Market

12 APAC’s Autologous Cell Therapy Market

13 Competitive Landscape

14 Company Profiles

15 Appendix

Companies Mentioned

  • Bayer Ag
  • BrainStorm Cell Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Castle Creek Biosciences, Inc.
  • Cytori Therapeutics Inc.
  • Dendreon Pharmaceuticals LLC
  • Eurofins Scientific SE
  • Fibrocell
  • FUJIFILM Holdings Corp.
  • Holostem Terapie Avanzate S.r.l.
  • Lineage Cell Therapeutics, Inc.
  • Novartis Ag
  • Orgenesis, Inc.
  • Regeneus Ltd.
  • RegenOrthoSport
  • Sangamo Therapeutics, Inc.
  • Smith and Nephew PLC
  • Sumitomo Chemical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Vericel Corp.

For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 12/22/2022 01:13 PM/DISC: 12/22/2022 01:13 PM